IN Control clinical audit: INsulin INitiation and INtensification to avoid clinical INertia
Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.
Diabetes treatment trials and tribulations: Overcoming therapeutic inertia - On-demand webinar
How can we encourage our patients to reach and maintain optimal glycaemic control in type 2 diabetes (T2D)? Often we need to rationalise what’s not working to be able to choose solutions that will work. Join international expert Prof Kamlesh Khunti and two local experts, A/Prof Marg McGIll and Dr Gary Deed in an engaging, interactive, on-demand webinar experience – customised for you.
